Curasight Gets CTA Nod for Ph1 uTREAT Trial in Brain Cancer
26 Aug 2025 //
PR NEWSWIRE
Curasight A/S Achieves First Milestone under collaboration with Curium Inc.
22 Jan 2024 //
PR NEWSWIRE
Curasight A/S reports positive preclinical results with uTREAT
07 Jun 2023 //
PR NEWSWIRE
Curasight and Curium announce global partnership for uTRACE® in prostate cancer
01 May 2023 //
PR NEWSWIRE